Cellectis
CLLS
74 hedge funds and large institutions have $259M invested in Cellectis in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 32 reducing their positions, and 18 closing their positions.
5% more capital invested
Capital invested by funds: $247M → $259M (+$11.4M)
0.83% more ownership
Funds ownership: 32.77% → 33.6% (+0.83%)
6% less funds holding
Funds holding: 79 → 74 (-5)
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
59% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$24.1M |
| 2 |
B
Bpifrance
Maisons Alfort, Cedex,
France
|
+$7.55M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.04M |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$1.03M |
| 5 |
Goldman Sachs
New York
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$5.34M |
| 2 |
Morgan Stanley
New York
|
-$4.92M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.96M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.37M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.67M |
CLLS Hedge Fund Activity: Q3 2020 in Review
74 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2020, worth a combined $259M — up 4.6% from $247M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CLLS and 13 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 13 added.
The largest buyer was ARK Investment Management, adding an estimated $24.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $5.34M sold.
- 74 institutional investors held Cellectis (CLLS) as of Q3 2020, down from 79 in Q2 2020.
- Funds reported $259M of Cellectis stock for Q3 2020, up 4.6% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q3 2020 and 18 closed out, a net change of -5 holders.
- The largest Cellectis buyer in Q3 2020 was ARK Investment Management, an estimated $24.1M added.
- The largest Cellectis seller in Q3 2020 was Adage Capital Partners, an estimated $5.34M sold.
Based on aggregated 13F filings for Q3 2020.